« Back to Record
Citation APA

Van Paemel, R., Vandeputte, C., Raman, L., Van Thorre, J., Willems, L., Van Dorpe, J., Van Der Linden, M., De Wilde, J., De Koker, A., Menten, B., Devalck, C., Vicha, A., Grega, M., Schleiermacher, G., Iddir, Y., Chicard, M., van Zogchel, L., Stutterheim, J., Lak, N. N., Tytgat, G. G., Laureys, G., Speleman, F., De Wilde, B., Lammens, T., De Preter, K., & Van Roy, N. (2021). The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples. European journal of cancer. doi:10.1016/j.ejca.2021.09.022


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/335193

Van Paemel, R., Vandeputte, C., Raman, L., Van Thorre, J., Willems, L., Van Dorpe, J., Van Der Linden, M., De Wilde, J., De Koker, A., Menten, B., Devalck, C., Vicha, A., Grega, M., Schleiermacher, G., Iddir, Y., Chicard, M., van Zogchel, L., Stutterheim, J., Lak, N. N., Tytgat, G. G., Laureys, G., Speleman, F., De Wilde, B., Lammens, T., De Preter, K., & Van Roy, N. (2021). The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples. European journal of cancer. doi:10.1016/j.ejca.2021.09.022